Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 12, 2012, Pages 2839-2846

  Collins, Alan R ^a,b   Gupte, Anisha A ^a,b   Ji, Ruirui ^a,b   Ramirez, Maricela R ^a,b   Minze, Laurie J ^a,b   Liu, Joey Z ^a,b   Arredondo, Magda ^d   Ren, Yuelan ^b   Deng, Tuo ^a,b   Wang, Jun ^a,b   Lyon, Christopher J ^a,b   Hsueh, Willa A ^a,b,c  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Methodist Diabetes and Metabolism Institute   (United States)

^d SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

Author keywords

atherosclerosis; diabetes mellitus; inflammation; nuclear factor (erythroid derived 2) like 2 factor; obesity; oxidative stress

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; BONE MARROW CELL; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE DELETION; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIPID DIET; LIVER FIBROSIS; LIVER INJURY; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; COMORBIDITY; DISEASE MODELS, ANIMAL; GENE DELETION; HYPERCHOLESTEROLEMIA; LIVER CIRRHOSIS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; NF-E2-RELATED FACTOR 2; OBESITY; OXIDATIVE STRESS; RECEPTORS, LDL; RISK FACTORS;

EID: 84870065736     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300345     Document Type: Article

References (48)

1. Collins AR, Lyon CJ, Xia X, Liu JZ, Tangirala RK, Yin F, Boyadjian R, Bikineyeva A, Praticò D, Harrison DG, Hsueh WA. Ageaccelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res. 2009;104:e42-e54.
2. Gupte AA, Liu JZ, Ren Y, Minze LJ, Wiles JR, Collins AR, Lyon CJ, Pratico D, Finegold MJ, Wong ST, Webb P, Baxter JD, Moore DD, Hsueh WA. Rosiglitazone attenuates age and dietassociated nonalcoholic steatohepatitis in male lowdensity lipoprotein receptor knockout mice. Hepatology. 2010;52:2001-2011.
3. Targher G, Bertolini L, Padovani R, Rodella S, Arcaro G, Day C. Differences and similarities in early atherosclerosis between patients with nonalcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol. 2007;46:1126-1132. (Pubitemid 46669732)
4. Ungvari Z, BaileyDowns L, Gautam T, Jimenez R, Losonczy G, Zhang C, Ballabh P, Recchia FA, Wilkerson DC, Sonntag WE, Pearson K, de Cabo R, Csiszar A. Adaptive induction of NFE2related factor2driven antioxidant genes in endothelial cells in response to hyperglycemia. Am J Physiol Heart Circ Physiol. 2011;300:H1133-H1140.
5. Ungvari Z, BaileyDowns L, Gautam T, Sosnowska D, Wang M, Monticone RE, Telljohann R, Pinto JT, de Cabo R, Sonntag WE, Lakatta EG, Csiszar A. Ageassociated vascular oxidative stress, Nrf2 dysfunction, and NF{kappa}B activation in the nonhuman primate Macaca mulatta. J Gerontol A Biol Sci Med Sci. 2011;66:866-875.
6. Ungvari Z, BaileyDowns L, Sosnowska D, Gautam T, Koncz P, Losonczy G, Ballabh P, de Cabo R, Sonntag WE, Csiszar A. Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of NRF2mediated antioxidant response. Am J Physiol Heart Circ Physiol. 2011;301:H363-H372.
7. Barajas B, Che N, Yin F, Rowshanrad A, Orozco LD, Gong KW, Wang X, Castellani LW, Reue K, Lusis AJ, Araujo JA. NFE2related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection. Arterioscler Thromb Vasc Biol. 2011;31:58-66.
8. Freigang S, Ampenberger F, Spohn G, Heer S, Shamshiev AT, Kisielow J, Hersberger M, Yamamoto M, Bachmann MF, Kopf M. Nrf2 is essential for cholesterol crystalinduced inflammasome activation and exacerbation of atherosclerosis. Eur J Immunol. 2011;41:2040-2051.
9. Chowdhry S, Nazmy MH, Meakin PJ, DinkovaKostova AT, Walsh SV, Tsujita T, Dillon JF, Ashford ML, Hayes JD. Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radical Biology & Medicine. 2011;48:357-371.
10. Sugimoto H, Okada K, Shoda J, Warabi E, Ishige K, Ueda T, Taguchi K, Yanagawa T, Nakahara A, Hyodo I, Ishii T, Yamamoto M. Deletion of nuclear factorE2related factor2 leads to rapid onset and progression of nutritional steatohepatitis in mice. Am J Physiol Gastrointest Liver Physiol. 2011;298:G283-294.
11. Videla LA, Rodrigo R, Orellana M, et al. Oxidative stressrelated parameters in the liver of nonalcoholic fatty liver disease patients. Clin Sci. 2004;106:261-268. (Pubitemid 38365832)
12. Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, Moore DD, Auwerx J. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP1c. J Clin Invest. 2004;113:1408-1418. (Pubitemid 39071696)
13. Tanaka Y, Aleksunes LM, Yeager RL, Gyamfi MA, Esterly N, Guo GL, Klaassen CD. NFE2related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a highfat diet. J Pharmacol Exp Ther. 2008;325:655-664. (Pubitemid 351574806)
14. Huang J, TabbiAnneni I, Gunda V, Wang L. Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. Am J Physiol Gastrointest Liver Physiol. 2010;299:G1211-G1221.
15. Tomita K, Tamiya G, Ando S, et al. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of nonalcoholic steatohepatitis in mice. Gut. 2006;55:415-424. (Pubitemid 43268283)
16. Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, Lütjohann D, Kerksiek A, van Kruchten R, Maeda N, Staels B, van Bilsen M, ShiriSverdlov R, Hofker MH. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology. 2008;48:474-486.
17. Collins AR, Meehan WP, Kintscher U, Jackson S, Wakino S, Noh G, Palinski W, Hsueh WA, Law RE. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptordeficient mice. Arterioscler Thromb Vasc Biol. 2001;21:365-371. (Pubitemid 32199117)
18. Li YM, Baviello G, Vlassara H, Mitsuhashi T. Glycation products in aged thioglycollate medium enhance the elicitation of peritoneal macrophages. J Immunol Methods. 1997;201:183-188. (Pubitemid 27086715)
19. Hsueh W, Abel ED, Breslow JL, Maeda N, Davis RC, Fisher EA, Dansky H, McClain DA, McIndoe R, Wassef MK, RabadánDiehl C, Goldberg IJ. Recipes for creating animal models of diabetic cardiovascular disease. Circ Res. 2007;100:1415-1427. (Pubitemid 46834754)
20. Daugherty A, Whitman SC. Quantification of atherosclerosis in mice. Methods Mol Biol. 2003;209:293-309.
21. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, UnalpArida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-1321. (Pubitemid 40770284)
22. Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, Glass CK. Peroxisome proliferatoractivated receptor gamma ligands inhibit development of atherosclerosis in LDL receptordeficient mice. J Clin Invest. 2000;106:523-531. (Pubitemid 30666385)
23. Thorp E, Li G, Seimon TA, Kuriakose G, Ron D, Tabas I. Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe/and Ldlr/mice lacking CHOP. Cell Metab. 2009;9:474-481.
24. Tsukano H, Gotoh T, Endo M, Miyata K, Tazume H, Kadomatsu T, Yano M, Iwawaki T, Kohno K, Araki K, Mizuta H, Oike Y. The endoplasmic reticulum stressC/EBP homologous protein pathwaymediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2011;30:1925-1932.
25. Lim WS, Timmins JM, Seimon TA, Sadler A, Kolodgie FD, Virmani R, Tabas I. Signal transducer and activator of transcription1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo. Circulation. 2008;117:940-951. (Pubitemid 351272592)
26. Kubota T, Kubota N, Moroi M, Terauchi Y, Kobayashi T, Kamata K, Suzuki R, Tobe K, Namiki A, Aizawa S, Nagai R, Kadowaki T, Yamaguchi T. Lack of insulin receptor substrate2 causes progressive neointima formation in response to vessel injury. Circulation. 2003;107:3073-3080. (Pubitemid 36758982)
27. Thorp E, Li Y, Bao L, Yao PM, Kuriakose G, Rong J, Fisher EA, Tabas I. Brief report: increased apoptosis in advanced atherosclerotic lesions of Apoe/mice lacking macrophage Bcl2. Arterioscler Thromb Vasc Biol. 2009;29:169-172.
28. Merchant AA, Singh A, Matsui W, Biswal S. The redoxsensitive transcription factor, Nrf2, regulates murine hematopoietic stem cell survival independent of ROS levels. Blood. 2011;118:6572-6579.
29. Pedrosa AM, Faine LA, Grosso DM, de Las Heras B, Boscá L, Abdalla DS. Electronegative LDL induction of apoptosis in macrophages: involvement of Nrf2. Biochim Biophys Acta. 2010;1801:430-437.
30. Ishii Y, Itoh K, Morishima Y, Kimura T, Kiwamoto T, Iizuka T, Hegab AE, Hosoya T, Nomura A, Sakamoto T, Yamamoto M, Sekizawa K. Transcription factor Nrf2 plays a pivotal role in protection against elastaseinduced pulmonary inflammation and emphysema. J Immunol. 2005;175:6968-6975. (Pubitemid 41598943)
31. Bruemmer D, Collins AR, Noh G, Wang W, Territo M, AriasMagallona S, Fishbein MC, Blaschke F, Kintscher U, Graf K, Law RE, Hsueh WA. Angiotensin IIaccelerated atherosclerosis and aneurysm formation is attenuated in osteopontindeficient mice. J Clin Invest. 2003;112:1318-1331. (Pubitemid 38057686)
32. Dawson TC, Kuziel WA, Osahar TA, Maeda N. Absence of CC chemokine receptor2 reduces atherosclerosis in apolipoprotein Edeficient mice. Atherosclerosis. 1999;143:205-211. (Pubitemid 29138720)
33. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. Absence of monocyte chemoattractant protein1 reduces atherosclerosis in low density lipoprotein receptordeficient mice. Mol Cell. 1998;2:275-281. (Pubitemid 128373654)
34. Park JG, Oh GT. The role of peroxidases in the pathogenesis of atherosclerosis. BMB Rep. 2011;44:497-505.
35. Yang H, Roberts LJ, Shi MJ, Zhou LC, Ballard BR, Richardson A, Guo ZM. Retardation of atherosclerosis by overexpression of catalase or both Cu/Znsuperoxide dismutase and catalase in mice lacking apolipoprotein E. Circ Res. 2004;95:1075-1081. (Pubitemid 39557894)
36. Hodara R, Weiss D, Joseph G, VelasquezCastano JC, Landázuri N, Han JW, Yoon YS, Taylor WR. Overexpression of catalase in myeloid cells causes impaired postischemic neovascularization. Arterioscler Thromb Vasc Biol. 2011;31:2203-2209.
37. Maicas N, Ferrándiz ML, Brines R, Ibáñez L, Cuadrado A, Koenders MI, van den Berg WB, Alcaraz MJ. Deficiency of Nrf2 accelerates the effector phase of arthritis and aggravates joint disease. Antioxid Redox Signal. 2011;15:889-901.
38. Rachakonda G, Sekhar KR, Jowhar D, Samson PC, Wikswo JP, Beauchamp RD, Datta PK, Freeman ML. Increased cell migration and plasticity in Nrf2deficient cancer cell lines. Oncogene. 2010;29:3703-3714.
39. Sussan TE, Jun J, Thimmulappa R, Bedja D, Antero M, Gabrielson KL, Polotsky VY, Biswal S. Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoEmediated atherosclerosis in mice. PLoS ONE. 2008;3:e3791.
40. Schreyer SA, Lystig TC, Vick CM, LeBoeuf RC. Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity. Atherosclerosis. 2003;171:49-55. (Pubitemid 37464628)
41. Karagiannides I, Abdou R, Tzortzopoulou A, Voshol PJ, Kypreos KE. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice. FEBS J. 2008;275:4796-4809.
42. Graeser AC, BoeschSaadatmandi C, Lippmann J, Wagner AE, Huebbe P, Storm N, Hoppner W, Wiswedel I, Gardemann A, Minihane AM, Doring F, Rimbach G. Nrf2dependent gene expression is affected by the proatherogenic apoE4 genotypestudies in targeted gene replacement mice. J Mol Med. 2011;89:1027-1035.
43. Kuchibhotla S, Vanegas D, Kennedy DJ, Guy E, Nimako G, Morton RE, Febbraio M. Absence of CD36 protects against atherosclerosis in ApoE knockout mice with no additional protection provided by absence of scavenger receptor A I/II. Cardiovasc Res. 2008;78:185-196. (Pubitemid 351430949)
44. Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2011;464:1357-1361.
45. Tomobe K, Shinozuka T, Kuroiwa M, Nomura YmeAgerelated changes of Nrf2 and phosphorylated GSK3beta in a mouse model of accelerated aging (SAMP8). Arch Gerontol Geriatr. 2011;54:e1-e7.
46. Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L. Molecular mechanisms involved in NAFLD progression. J Mol Med. 2009;87:679-695.
47. Sun LY, Bokov AF, Richardson A, Miller RA. Hepatic response to oxidative injury in longlived Ames dwarf mice. FASEB J. 2011;25:398-408.
48. Meher AK, Sharma PR, Lira VA, Yamamoto M, Kensler TW, Yan Z, Leitinger N. Nrf2 deficiency in myeloid cells is not sufficient to protect mice from highfat dietinduced adipose tissue inflammation and insulin resistance. Free Radic Biol Med. 2012;52:1708-1715.